|
Generic Name : Autologous Cultured Chondrocytes
Pronunciation : KON-droe-sites, aw-TALL-oh-gus KUL-cherd
Trade Name(s):
International- Carticel. This medication is an autologous (using the patient's own cells) cellular product, prescribed for the repair of symptomatic cartilage defects of the femoral condyle. When it is not to be taken (Contraindications):
When it is to be taken : Cell doses per cm² of defect- 0.64 million to 3.3 million cells/cm How it should be taken : It comes as a vial, which contains approximately 12 million cells, should be inserted into the affected area. Special Instruction : * Caution should be exercised in people who are at risk of infections, children, pregnant and breastfeeding women. Side Effects : Interventions during subsequent surgical procedures- Surgical removal of cartilage lesion, scars, surgical removal of joint tissue, surgery of the cartilage, removal of a torn meniscus (common knee joint injury), microfracture, scar tissue removal, hardware removal, joint surgeries. Most Serious - Injury complications, graft overgrowth, knee pain, cartilage injury, graft complication, meniscal lesion, graft failure, joint inflammation. Storage Conditions : Store it at room temperature. Do not freeze. |
![]() Comment & Contribute
![]()
![]() ![]() | ||


